CClinicalTrials.gg
WithdrawnNCT03797430SEBTHANDUpdated Jul 17, 2020

Determination of Normal Values for the Star Excursion Balance Test (SEBT) in Handball Players

An observational study in Handball Players, sponsored by University Hospital, Brest. Withdrawn. Open to female participants aged 14 Years to 18 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2020-07-17.

Sponsored by University Hospital, Brest · Observational

Why this study was withdrawn
NO PARTICIPANTS ENROLLED
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
0
Ages
14 Years to 18 Years
Sex
Female
01

Study summary

the aim of this study is to determine normal values for SEBT in young national or international handball women players for determining specific level for SEBT to predict risk of injury

02

Conditions studied

  • Handball Players

Keywords

  • hand ball
  • evaluation
  • risk of injury
  • women
03

In context

Lead sponsor

University Hospital, Brest is the lead sponsor of 594 studies on the registry; 135 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
14 Years to 18 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

national or international hanball women players, aged from 14 to 18 years old

Inclusion criteria

  • women
  • age from 14 to 18 years old
  • national or international level for handball

Exclusion criteria

Exclusion Criteria:

  • no french language
  • players who don't understand the instructions to perform the test
  • Refusal to perform the test
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
0 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. determination of normal values for SEBT

    star excursion balance test : it is a functionnal test for predicting the risk of injury

    Time frame: one day

07

Study locations

No study locations are listed for this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 17, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03797430
Lead sponsor
University Hospital, Brest
Responsible party
Sponsor
First posted
Jan 9, 2019
Start date
Jan 2, 2019 (estimated)
Primary completion
Jan 2, 2020 (estimated)
Completion
Jan 2, 2020 (estimated)
Last update
Jul 17, 2020

Study contacts

Marc BEAUMONT, PhD
principal investigator · CHU Brest

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is withdrawn, as verified in Jul 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion